TLR4 and acute kidney injury: Given the role of TLR4 in the pathogenesis of AKI, several therapeutic modulators have been devised to regulate TLR4 expression These compounds can be categorized as antibodies, small-molecule inhibitors, peptides, microRNAs, nanoparticles, lipid A analogs, and derivatives of natural products [124,125,126,127].